Home Acticor Biotech

Acticor Biotech

In operation
IPO
Ischemic Stroke Treatment Drug Developer

Basic Information

Acticor Biotech is a biopharmaceutical company developing innovative drugs for the acute phase of ischemic stroke.Acticor Biotech's project stems from an urgent need for new treatments for stroke.
Acticor Biotech SAS
Paris,Ile-de-France,France
15~50 people
November 01, 2013
contact@acticor-biotech.com